申请人:Lantern Pharma Inc.
公开号:US20210198191A1
公开(公告)日:2021-07-01
This invention provides illudin derivatives, intermediates, preparation methods, pharmaceutical compositions and uses thereof. Specific examples include novel synthetic routes to prepare illudin derivatives and an illudin derivative having a positive optical rotation, which has therapeutic value.